Putnam Investments’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Putnam Investments’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-99,838	Closed	-$10M	–	1619
2015 Q1	$10M	Hold	99,838	–	–	0.02%	498
2014 Q4	$5.24M	Sell	99,838 -63,900	-39%	-$1.88M	0.01%	760
2014 Q3	$4.2M	Hold	163,738	–	–	0.01%	823
2014 Q2	$3.65M	Sell	163,738 -700	-0.4%	-$15.3K	0.01%	877
2014 Q1	$5.06M	Buy	+164,438	New	+$4.42M	0.01%	757

Putnam Investments's ASPX Position: Q2 2015 in Review

Putnam Investments sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 99,838 shares — an estimated $10M sold.

Putnam Investments first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $10M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

Putnam Investments reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Putnam Investments sold 99,838 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $10M.
Putnam Investments first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
Putnam Investments's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $10M in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Putnam Investments's 13F filing for Q2 2015, filed 14 Aug 2015.